(HMN)

Reporting relationship: President & CEO, Director
Issuer ticker: HMN
Reported as of: 03 Aug 2026
Net transaction value: -$390,248
SEC form: 4
Accepted by SEC: 05 Aug 2026, 12:26:30 UTC
Prior SEC filing: 02 Jul 2026
Source filing: View source filing
Reporting owner signature: Linea K. Crouse, Attorney in Fact for Marita Zuraitis

Key filing fact

ZURAITIS MARITA filed Form 4 for HORACE MANN EDUCATORS CORP /DE/ (HMN) on 05 Aug 2026.

Key facts

This page summarizes ZURAITIS MARITA's Form 4 filing for HORACE MANN EDUCATORS CORP /DE/ (HMN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Aug 2026, 12:26.

Change

Previous filing in this sequence was filed on 02 Jul 2026.
Current net transaction value: -$390,248.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001198960 Primary reporting owner

ZURAITIS MARITA

Relationship: President & CEO, Director
Address: 1 HORACE MANN PLAZA, SPRINGFIELD
Signature: Linea K. Crouse, Attorney in Fact for Marita Zuraitis
Signature date: 05 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HMN transaction

Common Stock

Sale

Transaction value: $390,248
Shares: -7,500
Change %: -2.4%
Price: $52.03
Shares after: 307,129
Date: 03 Aug 2026
Ownership: Direct
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.59 to $52.59.

Footnote F3

Represents 217,395.305 vested restricted stock units and 89,734 shares of Common Stock.